NewAmsterdam Pharma Granted Inducement Stock Awards
The company issued stock options and units to seven new hires to incentivize their acceptance of employment.
Updated on Oct. 2, 2026 in People
Live Poll
Is it fair for companies to use large stock-based grants to attract new executive hires?
NewAmsterdam Pharma awarded 71,800 share options and 17,745 restricted stock units to seven new non-executive employees. These grants were issued as material inducements for the new hires to join the organization.
Why it matters
Companies use these equity-based inducement grants to attract specialized talent without depleting immediate cash reserves. By utilizing vesting schedules, the firm aligns long-term employee retention with shareholder interests.
The firm granted 71,800 options at an exercise price of $24.16, based on the October 1, 2026, closing stock price. Total awards include 17,745 restricted stock units issued under the 2024 Inducement Plan.
The players
NewAmsterdam Pharma
A Netherlands-based pharmaceutical company focused on the development of therapies for cardiometabolic diseases.
Nasdaq
A global financial services corporation that operates a stock exchange and sets listing requirements for public companies.
The details
The share options vest over four years, with 25% hitting the one-year anniversary and the remainder vesting in 36 equal monthly installments. Restricted stock units follow a three-year schedule, vesting in three equal annual installments. These grants comply with Nasdaq Listing Rule 5635(c)(4), which allows for equity inducement awards to new employees outside of shareholder-approved plans.
Timeline
October 1, 2026: Share options and restricted stock units were granted.
October 2, 2026: The inducement grants were publicly announced.
Market Landscape
Public companies frequently leverage Nasdaq Listing Rule 5635(c)(4) to issue equity outside of standard incentive plans when recruiting key personnel. This strategy allows firms to compete for high-level talent while maintaining transparency with shareholders regarding share dilution.
Operators should review their own equity compensation structures to ensure they comply with exchange-specific inducement rules. Benchmarking exercise prices against recent closing market values remains a standard governance requirement to avoid scrutiny.
The takeaway
Using equity-based inducements requires strict adherence to internal committee approval processes and exchange listing standards. Ensure your compensation committee maintains detailed records of grant dates and vesting schedules to satisfy future audit requirements.
Further reading
For more on executive and employee compensation trends, visit our People section.
Live Poll
Is it fair for companies to use large stock-based grants to attract new executive hires?
